Previous Article | Next Article ![]()
Infect Immun, February 1998, p. 462-468, Vol. 66, No. 2
Departments of
Medicine1 and
Molecular
Microbiology,3 Washington University School of
Medicine, St. Louis, Missouri 63110, and
Department of
Microbiology, University of Colorado Health Sciences Center,
Denver, Colorado 802622
Received 27 June 1997/Returned for modification 7 August
1997/Accepted 27 October 1997
One strategy for the induction of mucosal immune responses by oral
immunization is to administer the antigen in conjunction with cholera
toxin. Cholera toxin consists of one A polypeptide (CTA) which is
noncovalently linked to five B subunits (CTB) via the
A2 portion of the A subunit (CTA2). Coupling of
antigens to the nontoxic B subunit of cholera toxin may improve the
immunogenicity of antigens by targeting them to GM1 ganglioside on M
cells and intestinal epithelial cells. Here, we describe the
construction of a translational fusion protein containing the
serine-rich Entamoeba histolytica protein (SREHP), a
protective amebic antigen, fused to a maltose binding protein (MBP) and
to CTA2. When coexpressed in Escherichia coli
with the CTB gene, these proteins assembled into a holotoxin-like
chimera containing MBP-SREHP-CTA2 and CTB. This
holotoxin-like chimera (SREHP-H) inhibited the binding of cholera toxin
to GM1 ganglioside. Oral vaccination of mice with SREHP-H induced
mucosal immunoglobulin A (IgA) and serum IgG antiamebic antibodies and
low levels of mucosal anti-CTB antibodies. Our studies confirm that the
genetic coupling of antigens to CTA2 and their coexpression
in E. coli can produce holotoxin-like molecules that are
mucosally immunogenic without the requirement for supplemental cholera
toxin, and they establish the SREHP-H protein as a candidate for
evaluation as a vaccine to prevent amebiasis.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mucosal Immunogenicity of a Holotoxin-Like Molecule
Containing the Serine-Rich Entamoeba histolytica Protein
(SREHP) Fused to the A2 Domain of Cholera
Toxin

*
Corresponding author. Mailing address: Washington
University School of Medicine, Campus Box 8051, 660 S. Euclid Ave., St. Louis, MO 63110. Phone: (314) 362-1070. Fax: (314) 362-3525. E-mail: sstanley{at}im.wustl.edu.
Present address: Shaukat Khanum Memorial Cancer Hospital and
Research Center, Lahore, Pakistan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»